Mounjaro 2.5mg and 5mg bundle: what the first two doses are really for

The myth: low doses mean weak treatment

A common worry goes like this, if 2.5mg is the starting point and 15mg is the top, surely the early pens are doing very little. It is an understandable reading, but it misses the point of the schedule entirely.

Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it acts on two gut-hormone pathways at once. That is precisely why it is the only medicine of its kind licensed for weight management in the UK. It also means your body needs time to adjust. Starting at full therapeutic strength would, for most people, cause significant nausea and gastrointestinal discomfort. The 2.5mg pen is the prescriber's way of settling your system first, it is the opening chapter of a longer story, not the story itself.

The NHS patient information for tirzepatide describes exactly this: 2.5mg is prescribed at the start of treatment to help your body adapt, with the dose increased gradually by your prescriber from there. So the bundle is not a shortcut or a reduced version of the medicine, it is the prescribed entry point for everyone who starts.

This is also why the question of whether staying at 2.5mg produces weight loss deserves a careful, honest answer rather than a simple yes or no.

What does happen during weeks one to eight

That said, dismissing the first eight weeks entirely would be wrong in the other direction. Some people do notice appetite changes and early weight shifts at 2.5mg and 5mg. Tirzepatide slows gastric emptying and increases feelings of fullness regardless of dose, the mechanism is active from the first injection. Clinical trial results at higher doses are more striking, but the groundwork being laid in the early weeks is real.

What the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed was that average body-weight reductions of around 20–21% over 72 weeks were achieved at the 15mg maintenance dose. Those figures were built on a titration schedule that passed through exactly these early pens. There is no skip. The 2.5mg and 5mg period is part of why the higher doses work as well as they do, your system tolerates them better because you arrived gradually.

Practically, this period is also when most people get to grips with the injections themselves. Technique, rotating sites between abdomen, thigh and upper arm, and building the weekly habit all become second nature. If you are curious about the broader titration picture, the tirzepatide dosage schedule covers how the full ladder fits together.

Side effects are often most noticeable early on. Nausea, loose stools, indigestion and fatigue are the most frequently reported. For most people they are mild and settle within a couple of weeks as the body adapts, and because you are starting at the lowest dose, you are giving yourself the best chance of a smooth adjustment.

What the 5mg pen adds, and where to go next

Moving from 2.5mg to 5mg is the first titration step. The 5mg pen is still well below the doses where SURMOUNT trial participants saw the most significant results, but it does move the treatment forward. Many people find appetite suppression becomes a little more noticeable at this stage. Whether that step happens exactly at four weeks depends on how your prescriber's review goes, if side effects have been significant, they may suggest staying at 2.5mg a little longer. That decision belongs to your clinician, not a fixed calendar.

After 5mg, the licensed schedule continues upward through 7.5mg, 10mg, 12.5mg and up to 15mg, each step guided by how you are tolerating the previous dose and how your weight and health markers are progressing. You can read more about what the 5mg pen specifically involves, or look ahead to what the top of the dose range looks like with the Mounjaro 15mg pen.

Cost tends to be a question at this stage too. Mounjaro is priced by dose, and lower-dose pens sit at a different price point than the higher maintenance strengths. If you want to understand the broader pricing picture, the weight-loss treatments overview covers how private treatment is priced and what is included. Worth knowing: since Eli Lilly raised UK list prices in September 2025, reported private prices across providers have ranged roughly £149–£375 per month depending on dose, though individual providers vary.

Getting a Mounjaro prescription: what the process looks like

Mounjaro is a prescription-only medicine. That means the only legal route is an assessment by a qualified prescriber who decides (based on your health, your BMI and your history) whether treatment is appropriate and which dose to start you on. There is no shortcut around that, and honestly there should not be.

At nume, the process starts with a free consultation. A GPhC-registered Independent Prescriber reads your answers the same day, a named clinician, not an automated system. If treatment is clinically suitable, and you place your order before midday on a working day, your prescription is dispatched the same day and arrives free the next working day via DPD, in plain packaging. Every subsequent pen is reviewed again before it is issued; there is no auto-renewal or rolling subscription.

If you are already taking Mounjaro elsewhere and thinking about a 5mg bundle as your next step, you will need to provide evidence of your current treatment. That is a clinical safety check, not a bureaucratic one. If you would like to understand the full picture before starting, our Mounjaro overview covers the medicine from licence to results in one place. When you are ready, check your eligibility with a free consultation.